Evidence map›Paper›PMID 24714473›Full record

ArticleNature biotechnology2014

HIV eradication--from Berlin to Boston.

Paula M Cannon, Donald B Kohn, Hans-Peter Kiem

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. A novel anti-HIV immunotherapy to cure HIV.AIDS (London, England) · 2017
    Article
  4. Review
  5. Review
  6. Review
  7. Is the central nervous system a reservoir of HIV-1?Current opinion in HIV and AIDS · 2014
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paula M CannonUniversity of Southern California, Los Angeles, California, USA.
Donald B KohnUniversity of California Los Angeles, Los Angeles, California, USA.
Hans-Peter KiemFred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, USA.

Funding

ZFN-Modified Stem Cells for HIV EradicationU19AI096111 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSI, JOHN JOSEPH · 2011 to 2015
$20.8M
Transduction of Human Stem and Progenitor CellsP01HL073104 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOHN, DONALD B · 2003 to 2013
$18.3M
Development of Novel AIDS Gene Therapy Strategies in the Macaque SHIV ModelR01AI080326 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2009 to 2012
$2.2M
NHLBI NIH HHS P01 HL73104NIAID NIH HHS R01 AI080326NIAID NIH HHS U19 AI096111
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsHIV SeronegativityAnti-Retroviral AgentsBerlinBostonHematopoietic Stem Cell TransplantationHIV-1HumansLeukemiaLymphomaAnti-Retroviral Agents

Identifiers

PMID24714473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.